244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells-Reference-Cited by-同舟云学术

244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells

Published:2015-10-26 Issue:42 Volume:6 Page:44274-44288
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Yi¹²³⁴,Yao Ke¹²⁴,Shi Chengcheng¹³⁴,Jiang Yanan²,Liu Kangdong¹²⁴,Zhao Song³,Chen Hanyong¹,Reddy Kanamata¹,Zhang Chengjuan¹²⁵,Chang Xiaoyu¹,Ryu Joohyun¹,Bode Ann M.¹,Dong Ziming²,Dong Zigang¹⁴

Affiliation:

1. The Hormel Institute, University of Minnesota, Austin, MN, USA

2. Pathophysiology Department, Basic Medical College, Zhengzhou University, Henan, China

3. The First Affiliated Hospital of Zhengzhou University, Henan, China

4. The China-US (Henan) Hormel Cancer Institute, Henan, China

5. The Affiliated Cancer Hospital of Zhengzhou University, Henan, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application status and future prospects of the PDX model in lung cancer;Frontiers in Oncology;2023-03-24

2. A Method for the Establishment of Human Lung Adenocarcinoma Patient-Derived Xenografts in Mice;Methods in Molecular Biology;2021

3. Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer;Journal of Experimental & Clinical Cancer Research;2020-04-10

4. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization;Cell Death & Disease;2020-02

5. Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer;Respiratory Research;2018-12